Letter: Hyperthyroidism.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D005260:Female; D005313:Fetal Death; D005316:Fetal Distress; D005318:Fetal Heart / Q000187:drug effects; D005333:Fetus / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000150:complications / Q000188:drug therapy*; D007231:Infant, Newborn; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011263:Pregnancy Trimester, Third; D011433:Propranolol / Q000009:adverse effects* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011433:Propranolol